Sage Journals: Discover world-class research

Open access

Research article

First published 2023

PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis

Yoram Bouhnik, Bruno Fautrel, Laurent Beaugerie [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Long-term effectiveness,safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

Sarah Fischer, Sarah Cohnen, Entcho Klenske [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study

Davide Massimi, Brigida Barberio, Lorenzo Bertani [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study

Sarah Fischer, Moritz Donhauser, Sarah Cohnen [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2020-10

Diffusion MRI Derived per Area Vessel Density as a Surrogate Biomarker for Detecting Viral Hepatitis B-Induced Liver Fibrosis: A Proof-of-Concept Study

Ben-Heng Xiao, Hua Huang, Li-Fei Wang [...]

Journal of Laboratory Automation

Retricted access

Research article

First published 1985-9

The Generation of Stable Human T-Cell Hybridomas Which Constitutively Produce Interleukin-2 and Chemotactic Factor

Kenneth A. Foon, Jeffrey L. Rossio, Robert W. Schroff [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2025-11

Effect of maleic-anhydride and filler type on XNBR/IIR rubber blend

Bismark Mensah, Vitus Apalangya, Boateng Onwona-Agyeman [...]

Journal of Elastomers & Plastics

Open access

Review article

First published 2019

Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective

Ágnes Milassin, Anna Fábián, Tamás Molnár

Therapeutic Advances in Gastroenterology

Search results